Literature DB >> 23300082

Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways.

Patrick Quint1, Ming Ruan, Larry Pederson, Moustapha Kassem, Jennifer J Westendorf, Sundeep Khosla, Merry Jo Oursler.   

Abstract

Normal bone turnover requires tight coupling of bone resorption and bone formation to preserve bone quantity and structure. With aging and during several pathological conditions, this coupling breaks down, leading to either net bone loss or excess bone formation. To preserve or restore normal bone metabolism, it is crucial to determine the mechanisms by which osteoclasts and osteoblast precursors interact and contribute to coupling. We showed that osteoclasts produce the chemokine sphingosine 1-phosphate (S1P), which stimulates osteoblast migration. Thus, osteoclast-derived S1P may recruit osteoblasts to sites of bone resorption as an initial step in replacing lost bone. In this study we investigated the mechanisms by which S1P stimulates mesenchymal (skeletal) cell chemotaxis. S1P treatment of mesenchymal (skeletal) cells activated RhoA GTPase, but this small G protein did not contribute to migration. Rather, two S1P receptors, S1PR1 and S1PR2, coordinately promoted migration through activation of the JAK/STAT3 and FAK/PI3K/AKT signaling pathways, respectively. These data demonstrate that the chemokine S1P couples bone formation to bone resorption through activation of kinase signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23300082      PMCID: PMC3581421          DOI: 10.1074/jbc.M112.413583

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes.

Authors:  A Bonacchi; P Romagnani; R G Romanelli; E Efsen; F Annunziato; L Lasagni; M Francalanci; M Serio; G Laffi; M Pinzani; P Gentilini; F Marra
Journal:  J Biol Chem       Date:  2001-01-02       Impact factor: 5.157

2.  Antitumor activity of sphingosine kinase inhibitors.

Authors:  Kevin J French; John J Upson; Staci N Keller; Yan Zhuang; Jong K Yun; Charles D Smith
Journal:  J Pharmacol Exp Ther       Date:  2006-04-21       Impact factor: 4.030

3.  Building a better sphingosine kinase-1 inhibitor.

Authors:  Kevin R Lynch
Journal:  Biochem J       Date:  2012-05-15       Impact factor: 3.857

4.  Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.

Authors:  Hirofumi Matsuyuki; Yasuhiro Maeda; Kazuhiro Yano; Kunio Sugahara; Kenji Chiba; Takayuki Kohno; Yasuyuki Igarashi
Journal:  Cell Mol Immunol       Date:  2006-12       Impact factor: 11.530

5.  Stromal cell-derived factor-1-induced LFA-1 activation during in vivo migration of T cell hybridoma cells requires Gq/11, RhoA, and myosin, as well as Gi and Cdc42.

Authors:  R D Soede; I S Zeelenberg; Y M Wijnands; M Kamp; E Roos
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

6.  CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells.

Authors:  Amalia Lamana; Pilar Martin; Hortensia de la Fuente; Laura Martinez-Muñoz; Aranzazu Cruz-Adalia; Marta Ramirez-Huesca; Cristina Escribano; Kathrin Gollmer; Mario Mellado; Jens V Stein; Jose Luis Rodriguez-Fernandez; Francisco Sanchez-Madrid; Gloria Martinez del Hoyo
Journal:  J Invest Dermatol       Date:  2011-03-17       Impact factor: 8.551

7.  Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function.

Authors:  David García-Bernal; Javier Redondo-Muñoz; Ana Dios-Esponera; Raphaël Chèvre; Elvira Bailón; Mercedes Garayoa; Nohemí Arellano-Sánchez; Norma C Gutierrez; Andrés Hidalgo; Angeles García-Pardo; Joaquin Teixidó
Journal:  J Pathol       Date:  2013-01       Impact factor: 7.996

8.  Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells.

Authors:  Janne L Simonsen; Cecilia Rosada; Nedime Serakinci; Jeannette Justesen; Karin Stenderup; Suresh I S Rattan; Thomas G Jensen; Moustapha Kassem
Journal:  Nat Biotechnol       Date:  2002-06       Impact factor: 54.908

9.  Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation.

Authors:  Frank Niessen; Florence Schaffner; Christian Furlan-Freguia; Rafal Pawlinski; Gourab Bhattacharjee; Jerold Chun; Claudia K Derian; Patricia Andrade-Gordon; Hugh Rosen; Wolfram Ruf
Journal:  Nature       Date:  2008-02-27       Impact factor: 49.962

10.  JAK/STAT signalling in Drosophila controls cell motility during germ cell migration.

Authors:  Stephen Brown; Martin P Zeidler; James E Castelli-Gair Hombría
Journal:  Dev Dyn       Date:  2006-04       Impact factor: 3.780

View more
  33 in total

1.  Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways.

Authors:  Megan M Weivoda; Ming Ruan; Christine M Hachfeld; Larry Pederson; Alan Howe; Rachel A Davey; Jeffrey D Zajac; Yasuhiro Kobayashi; Bart O Williams; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  J Bone Miner Res       Date:  2015-08-19       Impact factor: 6.741

2.  Platelet-activating factor receptor-mediated PI3K/AKT activation contributes to the malignant development of esophageal squamous cell carcinoma.

Authors:  J Chen; T Lan; W Zhang; L Dong; N Kang; S Zhang; M Fu; B Liu; K Liu; C Zhang; J Hou; Q Zhan
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

3.  Mechanisms of osteoclast-dependent bone formation.

Authors:  Anna Teti
Journal:  Bonekey Rep       Date:  2013-12-04

4.  Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL.

Authors:  David H H Molstad; Anna M Mattson; Dana L Begun; Jennifer J Westendorf; Elizabeth W Bradley
Journal:  J Biol Chem       Date:  2020-10-04       Impact factor: 5.157

Review 5.  Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned.

Authors:  Matthew T Drake; Bart L Clarke; Merry Jo Oursler; Sundeep Khosla
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 6.  Sphingolipid metabolism and its role in the skeletal tissues.

Authors:  Zohreh Khavandgar; Monzur Murshed
Journal:  Cell Mol Life Sci       Date:  2014-11-26       Impact factor: 9.261

7.  Identification of a 22 bp DNA cis Element that Plays a Critical Role in Colony Stimulating Factor 1-Dependent Transcriptional Activation of the SPHK1 Gene.

Authors:  Gang Qing Yao; Meiling Zhu; Joanne Walker; Karl Insogna
Journal:  Calcif Tissue Int       Date:  2020-04-03       Impact factor: 4.333

Review 8.  Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit.

Authors:  Natalie A Sims; T John Martin
Journal:  Bonekey Rep       Date:  2014-01-08

Review 9.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

10.  Transforming growth factor beta 1 induces CXCL16 and leukemia inhibitory factor expression in osteoclasts to modulate migration of osteoblast progenitors.

Authors:  Kuniaki Ota; Patrick Quint; Megan M Weivoda; Ming Ruan; Larry Pederson; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  Bone       Date:  2013-07-25       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.